Growing Older, Looking Better

By Merz Aesthetics, PRNE
Wednesday, March 23, 2011

Survey Finds Only 1 in 4 Women(1) Attribute Beauty to Youth

MONACO, March 24, 2011 - Merz Aesthetics released data today at the Anti-Aging Medicine World
Congress and MediSpa (AMWC) showing that only 24% of women polled in Merz'
"Face Value" Beauty Survey believe youth is what makes women beautiful. Women
were far more likely to say that "healthy skin," "a charming personality,"
"confidence," "sex appeal," and, perhaps surprisingly, "intelligence" and a
"sense of humor" are what make a woman beautiful.

Encouragingly, most of the women surveyed believe that a woman is
beautiful at every age. Nevertheless, a majority of women would want to
improve theirs looks as they get older and more than 45% of women expressed
that aesthetic procedures are a necessity not a luxury.

"While most women (70%) report becoming more confident as they age, more
than half (59%) say they will have aesthetic procedures to look the best they
can," said Jérôme Augustin, Senior Vice President Merz Aesthetics Europe.
"The Merz Aesthetics Full Facial approach, including products such as
Radiesse(R) and Belotero(R) offer women a range of products to achieve the
radiant and well-rested look they desire."

Overall, a majority of women surveyed (87%) believe it is possible to
stay attractive and beautiful despite fading of youth. This is confirmed by
the fact that more than half of women (56%) surveyed have already experienced
at least one aesthetic procedure. In fact, women were most likely to have had
a facial injectable as their first aesthetic procedure.

"As a dermatologist, I treat many women who hold similar beliefs to those
surveyed," said Sabine Zenker, MD, Munich, Germany. "They seek out facial
injectables, like dermal fillers from Merz Aesthetics because they want to
take control of how they look without dramatically changing their

About the Survey

The survey, conducted online in October 2010 by Harris Interactive and
commissioned by Merz, included 2,939 women from France (n=543), the United
(n=524), Italy (n=667), Spain (n=701), and Russia (n=504) who have
experience with, or interest in, using facial injectable treatments of dermal
fillers and other injectables. Women were asked a variety of questions about
their thoughts and feelings related to what makes a woman beautiful, their
own personal beauty, and the role of aesthetic procedures in maintaining
their appearance. For more information on survey methodology, including
weighting variables and subgroup sample sizes, please contact Danielle Lewis,
Medical Dynamics, +1 (212) 537-9495 or

About Merz Aesthetics

Merz Aesthetics Inc. is a division of Germany-based Merz Pharmaceuticals.
Merz Aesthetics Europe is headquartered in Frankfurt, Germany, operates
subsidiaries in 16 countries and cooperates with more than 30 distributors
all over the world.

Founded in 1908, Merz has more than a century of experience in improving
people's lives and has deep roots in dermatology. Merz Aesthetics is breaking
new scientific ground and is setting future industry standards, bringing
doctors and patients safe and effective products for use in the dermatology
and aesthetic treatment.

Merz Aesthetics' product portfolio includes Radiesse(R) volumising filler
and the BELOTERO(R) family of fillers for use in facial aesthetics as well as
other injectables. Asclera(R), a sclerosing agent for surface varicose veins,
was introduced to the United States in April 2010.

About Harris Interactive

Harris Interactive is one of the world's leading custom market research
firms, leveraging research, technology, and business acumen to transform
relevant insight into actionable foresight. Known widely for the Harris Poll
and for pioneering innovative research methodologies, Harris offers expertise
in a wide range of industries including healthcare, technology, public
affairs, energy, telecommunications, financial services, insurance, media,
retail, restaurant, and consumer package goods. Harris serves clients in over
215 countries and territories through its North American, European, and Asian
offices and a network of independent market research firms. For more
information, please visit

(1) "Women" refers to females ages 18+ who have experience with, or
interest in, using facial injectable treatments of dermal fillers and/or
botulinum toxin (n=2,939).

Merz Pharmaceuticals GmbH: Christine Keppler, Eckenheimer Landstrasse 100, D-60318 Frankfurt am Main, +49(069)1503-6900,; Media contact: Danielle Lewis, +1-917-907-4239, dlewis at; Local French media contact: Ségolène de Retz, +33(0)06-18-68-36-70, segolene.deretz at

will not be displayed